Lieven Gentaur Advancing RNA Synthesis: Exploring a Next-Generation Transcription Buffer efficient RNA synthesis is a cornerstone of research and development. The tools used for this process must meet rigorous standards to ensure accuracy and effectiveness. One of the latest innovations i... 30 août 2024
Lieven Gentaur Advancements in Laboratory Illumination Technology In scientific research, accurate illumination and safety are crucial. Laboratories require effective tools for observing experimental results, and advancements in light technology have played a signif... 29 août 2024
Lieven Gentaur FDA’s Lykos Rejection Delays—But Doesn’t Stop—Psychedelic Therapies Developers in the psychedelic field remain hopeful despite the FDA’s Complete Response Letter (CRL) issued on August 9 for Lykos Therapeutics’ MDMA-assisted treatment for PTSD. Experts anticipate that... 29 août 2024
Lieven Gentaur Regeneron Scores EU Lymphoma Approval for Bispecific Antibody Ordspono The European Commission granted approval to Regeneron’s bispecific antibody, Ordspono, on Monday, marking its first regulatory success worldwide. Ordspono is now authorized for treating relapsed or re... 28 août 2024
Lieven Gentaur Moderna Lays Foundations for Growth, but Can It Turn Strategy Into Execution? The vaccine manufacturer is up against established competitors in markets that face both demand issues and commercial obstacles, as the biotech seeks to find new avenues for growth. As the 2024–2025 r... 28 août 2024
